Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up
暂无分享,去创建一个
F. Fedele | M. Mancone | A. Maraone | P. Severino | A. D’Amato | Silvia Prosperi | M. Magnocavallo | Claudia Notari | Ilaria Papisca | S. Prosperi
[1] A. Fiorentino,et al. A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS , 2022, Frontiers in Cardiovascular Medicine.
[2] F. Fedele,et al. Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity? , 2022, Journal of clinical medicine.
[3] M. Wawrzyńska,et al. Telemedicine in Cardiology: Modern Technologies to Improve Cardiovascular Patients’ Outcomes—A Narrative Review , 2022, Medicina.
[4] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2022, European journal of heart failure.
[5] A. Budaj,et al. Impact of COVID‐19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV‐HF‐SIRIO 6 study) , 2021, ESC heart failure.
[6] F. Fedele,et al. Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient , 2021, Heart Failure Reviews.
[7] J. Spertus,et al. Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth Model , 2021, JACC: Heart Failure.
[8] F. Fedele,et al. Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets , 2021, International journal of molecular sciences.
[9] C. Lavalle,et al. Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown , 2021, Pacing and clinical electrophysiology : PACE.
[10] Sara Simões Dias,et al. Impact of telemedicine on the management of heart failure patients during coronavirus disease 2019 pandemic , 2021, ESC heart failure.
[11] Harleah G. Buck,et al. Examining Adherence and Dose Effect of an Early Palliative Care Intervention for Advanced Heart Failure Patients. , 2021, Journal of pain and symptom management.
[12] Kristen M. Tecson,et al. Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic , 2021, Heart Failure Reviews.
[13] M. Ciccarelli,et al. Artificial Intelligence as a Business Partner in Cardiovascular Precision Medicine: an Emerging Approach for Disease Detection and Treatment Optimization. , 2020, Current medicinal chemistry.
[14] F. Fedele,et al. Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak , 2020, ESC heart failure.
[15] C. Cunnington,et al. The impact of COVID‐19 on the management of heart failure: a United Kingdom patient questionnaire study , 2020, medRxiv.
[16] C. Gale,et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic , 2020, Heart.
[17] F. Fedele,et al. Management of cardiac implantable electronic device follow‐up in COVID‐19 pandemic: Lessons learned during Italian lockdown , 2020, Journal of cardiovascular electrophysiology.
[18] G. Hindricks,et al. Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak Insights from the German-wide Helios hospital network , 2020, European heart journal. Quality of care & clinical outcomes.
[19] C. Torp‐Pedersen,et al. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark , 2020, Circulation. Heart failure.
[20] R. D'Assante,et al. Heart failure management during the COVID‐19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre , 2020, European journal of heart failure.
[21] P. Ponikowski,et al. Management of heart failure patients with COVID‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.
[22] J. Ruidavets,et al. Telemonitoring versus standard care in heart failure: a randomised multicentre trial , 2020, European journal of heart failure.
[23] Furio Colivicchi,et al. The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure , 2020, Journal of Cardiac Failure.
[24] Michael E. Hall,et al. Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic , 2020, Journal of Cardiac Failure.
[25] E. Gronda,et al. Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door , 2020, Heart Failure Reviews.
[26] R. Clark,et al. Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic: the advantages of universal access to home telemonitoring , 2020, European journal of heart failure.
[27] C. Napoli,et al. A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors , 2020, International journal of environmental research and public health.
[28] N. Reza,et al. Secondary Impact of the COVID-19 Pandemic on Patients With Heart Failure , 2020, Circulation. Heart failure.
[29] Hongliang Li,et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. , 2020, Circulation.
[30] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[31] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[32] M. B. Jensen,et al. Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial , 2020, BMJ Open.
[33] Saravana Kumar,et al. Systematic review of patient and caregivers’ satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients’ health , 2019, PloS one.
[34] S. Ghio,et al. Early readmission for heart failure: An avoidable or ineluctable debacle? , 2019, International journal of cardiology.
[35] C. Ahn,et al. Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial. , 2018, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[36] N. Albert,et al. Factors Associated With Adherence to 14-Day Office Appointments After Heart Failure Discharge. , 2017, Journal of cardiac failure.
[37] Shannon M. Dunlay,et al. Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.
[38] Hai-Feng Zhang,et al. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis , 2017, Journal of Investigative Medicine.
[39] J. Portnoy,et al. Telemedicine is as effective as in-person visits for patients with asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[40] Deepak L. Bhatt,et al. Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure , 2016, Circulation: Heart Failure.
[41] Karl Swedberg,et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. , 2013, European heart journal.
[42] G. Fonarow,et al. Home monitoring for heart failure management. , 2012, Journal of the American College of Cardiology.
[43] C. Ng,et al. Why Do Patients With Chronic Illnesses Fail To Keep Their Appointments? A Telephone Interview , 2006, Asia-Pacific journal of public health.